163 related articles for article (PubMed ID: 28607403)
1. Quantification of within-sample genetic heterogeneity from SNP-array data.
Martinez P; Kimberley C; BirkBak NJ; Marquard A; Szallasi Z; Graham TA
Sci Rep; 2017 Jun; 7(1):3248. PubMed ID: 28607403
[TBL] [Abstract][Full Text] [Related]
2. Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer.
Yang C; Zhang S; Cheng Z; Liu Z; Zhang L; Jiang K; Geng H; Qian R; Wang J; Huang X; Chen M; Li Z; Qin W; Xia Q; Kang X; Wang C; Hang H
Genome Med; 2022 Dec; 14(1):142. PubMed ID: 36527145
[TBL] [Abstract][Full Text] [Related]
3. Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours.
Khalique L; Ayhan A; Weale ME; Jacobs IJ; Ramus SJ; Gayther SA
J Pathol; 2007 Feb; 211(3):286-95. PubMed ID: 17154249
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.
Hua X; Zhao W; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Zhu B; Wang M; Jones K; Hicks B; Song L; Sampson J; Wedge DC; Shi J; Landi MT
Nat Commun; 2020 May; 11(1):2459. PubMed ID: 32424208
[TBL] [Abstract][Full Text] [Related]
6. Measuring intratumor heterogeneity by network entropy using RNA-seq data.
Park Y; Lim S; Nam JW; Kim S
Sci Rep; 2016 Nov; 6():37767. PubMed ID: 27883053
[TBL] [Abstract][Full Text] [Related]
7. Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer.
Lubbock ALR; Stewart GD; O'Mahony FC; Laird A; Mullen P; O'Donnell M; Powles T; Harrison DJ; Overton IM
BMC Med; 2017 Jun; 15(1):118. PubMed ID: 28648142
[TBL] [Abstract][Full Text] [Related]
8. An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles.
Li M; Zhang Z; Li L; Wang X
Commun Biol; 2020 Sep; 3(1):505. PubMed ID: 32917965
[TBL] [Abstract][Full Text] [Related]
9. A transcriptomic intratumour heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma.
Luo S; Jia Y; Zhang Y; Zhang X
JHEP Rep; 2023 Jun; 5(6):100754. PubMed ID: 37234275
[TBL] [Abstract][Full Text] [Related]
10. Mutation divergence over space in tumour expansion.
Li H; Yang Z; Tu F; Deng L; Han Y; Fu X; Wang L; Gu D; Werner B; Huang W
J R Soc Interface; 2023 Nov; 20(208):20230542. PubMed ID: 37989227
[TBL] [Abstract][Full Text] [Related]
11. Tumour heterogeneity and immune-modulation.
Jamal-Hanjani M; Thanopoulou E; Peggs KS; Quezada SA; Swanton C
Curr Opin Pharmacol; 2013 Aug; 13(4):497-503. PubMed ID: 23664091
[TBL] [Abstract][Full Text] [Related]
12. SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq.
Kim M; Lee S; Lim S; Kim S
PLoS One; 2019; 14(10):e0223520. PubMed ID: 31644551
[TBL] [Abstract][Full Text] [Related]
13. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
Li L; Chen C; Wang X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
[TBL] [Abstract][Full Text] [Related]
14. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours.
Gavish A; Tyler M; Greenwald AC; Hoefflin R; Simkin D; Tschernichovsky R; Galili Darnell N; Somech E; Barbolin C; Antman T; Kovarsky D; Barrett T; Gonzalez Castro LN; Halder D; Chanoch-Myers R; Laffy J; Mints M; Wider A; Tal R; Spitzer A; Hara T; Raitses-Gurevich M; Stossel C; Golan T; Tirosh A; Suvà ML; Puram SV; Tirosh I
Nature; 2023 Jun; 618(7965):598-606. PubMed ID: 37258682
[TBL] [Abstract][Full Text] [Related]
15. Intra-tumor genetic heterogeneity in rectal cancer.
Hardiman KM; Ulintz PJ; Kuick RD; Hovelson DH; Gates CM; Bhasi A; Rodrigues Grant A; Liu J; Cani AK; Greenson JK; Tomlins SA; Fearon ER
Lab Invest; 2016 Jan; 96(1):4-15. PubMed ID: 26568296
[TBL] [Abstract][Full Text] [Related]
16. DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.
Song D; Wang X
J Transl Med; 2022 Apr; 20(1):150. PubMed ID: 35365157
[TBL] [Abstract][Full Text] [Related]
17. Genetic and non-genetic clonal diversity in cancer evolution.
Black JRM; McGranahan N
Nat Rev Cancer; 2021 Jun; 21(6):379-392. PubMed ID: 33727690
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal copy number heterogeneity predicts survival rates across cancers.
van Dijk E; van den Bosch T; Lenos KJ; El Makrini K; Nijman LE; van Essen HFB; Lansu N; Boekhout M; Hageman JH; Fitzgerald RC; Punt CJA; Tuynman JB; Snippert HJG; Kops GJPL; Medema JP; Ylstra B; Vermeulen L; Miedema DM
Nat Commun; 2021 May; 12(1):3188. PubMed ID: 34045449
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Multi-region and single-cell sequencing reveal variable genomic heterogeneity in rectal cancer.
Liu M; Liu Y; Di J; Su Z; Yang H; Jiang B; Wang Z; Zhuang M; Bai F; Su X
BMC Cancer; 2017 Nov; 17(1):787. PubMed ID: 29169336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
